Get Information, Interaction & Inspiration!
The SoPE Turkey Chapter is located in one of the most visited places on earth, the financial headquarter of Istanbul where there is a renaissance of healthcare and biotech entrepreneurship. You do not need to be a local to join our chapter, as we reach entrepreneurs nationally in Pharmaceutical, Medical Devices, Digital Health, and Biosciences. We welcome all those who are involved in the healthcare space.
Health Care entrepreneurship is strong and well for those who are interested in investing their time and energy in the development of a much needed healthcare product or service in Turkey. Whether you are looking to start your career through entrepreneurship or turn your passion into a second career, we have group expertise that can help you unlock the unique talent that is within you.
Join us! We meet at quarterly dinners where brilliant innovations and ideas are presented.
Five Top Reasons You Should Attend Turkey SoPE Chapter events
- 1. Learn by Example & perfect your own!
- 2. Understand what seasoned investors expect in real life terms
- 3. Networking with like-minded professionals
- 4. Create your own Due Diligence process
- 5. Be Part of It!
Yavuz S. Silay, MD, MBA
Dr. Silay is currently serving as the Director, Market Access & Health Policy for AIFD( Research Based Pharmaceutical Companies) which the 40 members represent all major global pharmaceutical companies, 650 billion dollars of 1 billion dollar Global Pharmaceutical market. Dr. Silay also serves as CEO of Labiopharma, LLC in US and as the CEO of ICG( Istanbul Consulting Group) in Turkey . He provides guidance to Turkish Ministry of health through a world bank project. His executive team is providing clinical trial administration, market access, medical writing, patient recruitment, retention, regulatory and medical affairs support, drug repositioning for academic institutions and pharmaceutical companies from preclinical to post marketing stages for several years. Dr. Silay is also providing comprehensive and strategic consulting services for the approval of Drugs and Medical Devices and attended several meetings with FDA, EMA, Health Canada and Turkish Health authorities.
Dr. Silay most recently worked as the Vice President, Medical Affairs, and head of Medical Affairs Neurology in the US headquarters Basking Ridge, New Jersey reporting to the President and CEO of Ipsen North America.
Dr.Silay previously worked at Teva Neuroscience from May 2009 through September 2011 as the head of clinical and medical Parkinson’s franchise and the Director of Scientific Affairs and Medical Research in U.S Headquarter in Kansas City reporting to Chief Medical Officer and VP of Medical Affairs. He was previously responsible for the Parkinson’s disease Investigator Initiated Trials, Phase IIIB, Phase IV trials and for developing relationships with Key Opinion Leaders in the field of Neurology.